+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Companion Animal Specialty Drugs Market 2024-2028

  • PDF Icon

    Report

  • 168 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5145589
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The companion animal specialty drugs market is forecasted to grow by USD 4553.55 mn during 2023-2028, accelerating at a CAGR of 6.68% during the forecast period. The report on the companion animal specialty drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pet humanization, rising awareness about disease prevention and pet insurance, and rise in aging companion animal population.

The companion animal specialty drugs market is segmented as below:

By Distribution Channel

  • Veterinary hospitals
  • Pet care clinics
  • Pharmacy stores

By Product

  • Vaccines
  • Antibiotics
  • Parasiticides
  • Feed additives
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the enhanced companion animal specialty drug offerings as one of the prime reasons driving the companion animal specialty drugs market growth during the next few years. Also, increase in m and a in the animal companion specialty drugs market and rising obesity in companion animals will lead to sizable demand in the market.

The report on the companion animal specialty drugs market covers the following areas:

  • Companion animal specialty drugs market sizing
  • Companion animal specialty drugs market forecast
  • Companion animal specialty drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion animal specialty drugs market vendors that include Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp.. Also, the companion animal specialty drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global companion animal specialty drugs market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global companion animal specialty drugs market 2018 - 2022 ($ million)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Veterinary hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
6.4 Pet care clinics - Market size and forecast 2023-2028
Exhibit 38: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
6.5 Pharmacy stores - Market size and forecast 2023-2028
Exhibit 42: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Vaccines - Market size and forecast 2023-2028
Exhibit 52: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
7.4 Antibiotics - Market size and forecast 2023-2028
Exhibit 56: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
7.5 Parasiticides - Market size and forecast 2023-2028
Exhibit 60: Chart on Parasiticides - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Parasiticides - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Parasiticides - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Parasiticides - Year-over-year growth 2023-2028 (%)
7.6 Feed additives - Market size and forecast 2023-2028
Exhibit 64: Chart on Feed additives - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on Feed additives - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Product
Exhibit 72: Market opportunity by Product ($ million)
Exhibit 73: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share by geography 2023-2028 (%)
Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 115: Market opportunity by geography ($ million)
Exhibit 116: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 123: Bayer AG - Overview
Exhibit 124: Bayer AG - Business segments
Exhibit 125: Bayer AG - Key news
Exhibit 126: Bayer AG - Key offerings
Exhibit 127: Bayer AG - Segment focus
12.4 Beaphar Beheer BV
Exhibit 128: Beaphar Beheer BV - Overview
Exhibit 129: Beaphar Beheer BV - Product / Service
Exhibit 130: Beaphar Beheer BV - Key offerings
12.5 Bimeda Holdings Ltd.
Exhibit 131: Bimeda Holdings Ltd. - Overview
Exhibit 132: Bimeda Holdings Ltd. - Product / Service
Exhibit 133: Bimeda Holdings Ltd. - Key offerings
12.6 Boehringer Ingelheim International GmbH
Exhibit 134: Boehringer Ingelheim International GmbH - Overview
Exhibit 135: Boehringer Ingelheim International GmbH - Business segments
Exhibit 136: Boehringer Ingelheim International GmbH - Key news
Exhibit 137: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 138: Boehringer Ingelheim International GmbH - Segment focus
12.7 Ceva Sante Animale
Exhibit 139: Ceva Sante Animale - Overview
Exhibit 140: Ceva Sante Animale - Product / Service
Exhibit 141: Ceva Sante Animale - Key offerings
12.8 Dechra Pharmaceuticals Plc
Exhibit 142: Dechra Pharmaceuticals Plc - Overview
Exhibit 143: Dechra Pharmaceuticals Plc - Business segments
Exhibit 144: Dechra Pharmaceuticals Plc - Key offerings
Exhibit 145: Dechra Pharmaceuticals Plc - Segment focus
12.9 Elanco Animal Health Inc.
Exhibit 146: Elanco Animal Health Inc. - Overview
Exhibit 147: Elanco Animal Health Inc. - Product / Service
Exhibit 148: Elanco Animal Health Inc. - Key offerings
12.10 LABORATORIOS CALIER S.A
Exhibit 149: LABORATORIOS CALIER S.A - Overview
Exhibit 150: LABORATORIOS CALIER S.A - Product / Service
Exhibit 151: LABORATORIOS CALIER S.A - Key offerings
12.11 Mars Inc.
Exhibit 152: Mars Inc. - Overview
Exhibit 153: Mars Inc. - Product / Service
Exhibit 154: Mars Inc. - Key news
Exhibit 155: Mars Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 156: Merck and Co. Inc. - Overview
Exhibit 157: Merck and Co. Inc. - Business segments
Exhibit 158: Merck and Co. Inc. - Key news
Exhibit 159: Merck and Co. Inc. - Key offerings
Exhibit 160: Merck and Co. Inc. - Segment focus
12.13 Neogen Corp.
Exhibit 161: Neogen Corp. - Overview
Exhibit 162: Neogen Corp. - Business segments
Exhibit 163: Neogen Corp. - Key news
Exhibit 164: Neogen Corp. - Key offerings
Exhibit 165: Neogen Corp. - Segment focus
12.14 Norbrook Laboratories Ltd.
Exhibit 166: Norbrook Laboratories Ltd. - Overview
Exhibit 167: Norbrook Laboratories Ltd. - Product / Service
Exhibit 168: Norbrook Laboratories Ltd. - Key offerings
12.15 Vetoquinol SA
Exhibit 169: Vetoquinol SA - Overview
Exhibit 170: Vetoquinol SA - Business segments
Exhibit 171: Vetoquinol SA - Key news
Exhibit 172: Vetoquinol SA - Key offerings
Exhibit 173: Vetoquinol SA - Segment focus
12.16 Virbac Group
Exhibit 174: Virbac Group - Overview
Exhibit 175: Virbac Group - Business segments
Exhibit 176: Virbac Group - Key news
Exhibit 177: Virbac Group - Key offerings
Exhibit 178: Virbac Group - Segment focus
12.17 Zoetis Inc.
Exhibit 179: Zoetis Inc. - Overview
Exhibit 180: Zoetis Inc. - Business segments
Exhibit 181: Zoetis Inc. - Key news
Exhibit 182: Zoetis Inc. - Key offerings
Exhibit 183: Zoetis Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 186: Currency conversion rates for US$
13.4 Research methodology
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
13.5 List of abbreviations
Exhibit 190: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global companion animal specialty drugs market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Distribution Channel ($ million)
Exhibits 47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 48: Chart on Product - Market share 2023-2028 (%)
Exhibits 49: Data Table on Product - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Product
Exhibits 51: Data Table on Comparison by Product
Exhibits 52: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Parasiticides - Market size and forecast 2023-2028 ($ million)
Exhibits 61: Data Table on Parasiticides - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Chart on Parasiticides - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Parasiticides - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Feed additives - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on Feed additives - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 72: Market opportunity by Product ($ million)
Exhibits 73: Data Table on Market opportunity by Product ($ million)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share by geography 2023-2028 (%)
Exhibits 76: Data Table on Market share by geography 2023-2028 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 108: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 109: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 111: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 112: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 113: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 114: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 115: Market opportunity by geography ($ million)
Exhibits 116: Data Tables on Market opportunity by geography ($ million)
Exhibits 117: Impact of drivers and challenges in 2023 and 2028
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: Bayer AG - Overview
Exhibits 124: Bayer AG - Business segments
Exhibits 125: Bayer AG - Key news
Exhibits 126: Bayer AG - Key offerings
Exhibits 127: Bayer AG - Segment focus
Exhibits 128: Beaphar Beheer BV - Overview
Exhibits 129: Beaphar Beheer BV - Product / Service
Exhibits 130: Beaphar Beheer BV - Key offerings
Exhibits 131: Bimeda Holdings Ltd. - Overview
Exhibits 132: Bimeda Holdings Ltd. - Product / Service
Exhibits 133: Bimeda Holdings Ltd. - Key offerings
Exhibits 134: Boehringer Ingelheim International GmbH - Overview
Exhibits 135: Boehringer Ingelheim International GmbH - Business segments
Exhibits 136: Boehringer Ingelheim International GmbH - Key news
Exhibits 137: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 138: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 139: Ceva Sante Animale - Overview
Exhibits 140: Ceva Sante Animale - Product / Service
Exhibits 141: Ceva Sante Animale - Key offerings
Exhibits 142: Dechra Pharmaceuticals Plc - Overview
Exhibits 143: Dechra Pharmaceuticals Plc - Business segments
Exhibits 144: Dechra Pharmaceuticals Plc - Key offerings
Exhibits 145: Dechra Pharmaceuticals Plc - Segment focus
Exhibits 146: Elanco Animal Health Inc. - Overview
Exhibits 147: Elanco Animal Health Inc. - Product / Service
Exhibits 148: Elanco Animal Health Inc. - Key offerings
Exhibits 149: LABORATORIOS CALIER S.A - Overview
Exhibits 150: LABORATORIOS CALIER S.A - Product / Service
Exhibits 151: LABORATORIOS CALIER S.A - Key offerings
Exhibits 152: Mars Inc. - Overview
Exhibits 153: Mars Inc. - Product / Service
Exhibits 154: Mars Inc. - Key news
Exhibits 155: Mars Inc. - Key offerings
Exhibits 156: Merck and Co. Inc. - Overview
Exhibits 157: Merck and Co. Inc. - Business segments
Exhibits 158: Merck and Co. Inc. - Key news
Exhibits 159: Merck and Co. Inc. - Key offerings
Exhibits 160: Merck and Co. Inc. - Segment focus
Exhibits 161: Neogen Corp. - Overview
Exhibits 162: Neogen Corp. - Business segments
Exhibits 163: Neogen Corp. - Key news
Exhibits 164: Neogen Corp. - Key offerings
Exhibits 165: Neogen Corp. - Segment focus
Exhibits 166: Norbrook Laboratories Ltd. - Overview
Exhibits 167: Norbrook Laboratories Ltd. - Product / Service
Exhibits 168: Norbrook Laboratories Ltd. - Key offerings
Exhibits 169: Vetoquinol SA - Overview
Exhibits 170: Vetoquinol SA - Business segments
Exhibits 171: Vetoquinol SA - Key news
Exhibits 172: Vetoquinol SA - Key offerings
Exhibits 173: Vetoquinol SA - Segment focus
Exhibits 174: Virbac Group - Overview
Exhibits 175: Virbac Group - Business segments
Exhibits 176: Virbac Group - Key news
Exhibits 177: Virbac Group - Key offerings
Exhibits 178: Virbac Group - Segment focus
Exhibits 179: Zoetis Inc. - Overview
Exhibits 180: Zoetis Inc. - Business segments
Exhibits 181: Zoetis Inc. - Key news
Exhibits 182: Zoetis Inc. - Key offerings
Exhibits 183: Zoetis Inc. - Segment focus
Exhibits 184: Inclusions checklist
Exhibits 185: Exclusions checklist
Exhibits 186: Currency conversion rates for US$
Exhibits 187: Research methodology
Exhibits 188: Validation techniques employed for market sizing
Exhibits 189: Information sources
Exhibits 190: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global companion animal specialty drugs market: Bayer AG, Beaphar Beheer BV, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Kyoritsuseiyaku Corp., LABORATORIOS CALIER S.A, Mars Inc., Merck and Co. Inc., Neogen Corp., Norbrook Laboratories Ltd., Tianjin ringpu bio-technology Co. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Orion Corp..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is enhanced companion animal specialty drug offerings.'

According to the report, one of the major drivers for this market is the increase in pet humanization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Beaphar Beheer BV
  • Bimeda Holdings Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Kyoritsuseiyaku Corp.
  • LABORATORIOS CALIER S.A
  • Mars Inc.
  • Merck and Co. Inc.
  • Neogen Corp.
  • Norbrook Laboratories Ltd.
  • Tianjin ringpu bio-technology Co. Ltd.
  • Vetoquinol SA
  • Virbac Group
  • Zenex Animal Health India Private Ltd.
  • Zoetis Inc.
  • Orion Corp.

Related Topics

Related Reports

Global Veterinary Eye Care Market 2024-2028 - Product Image

Global Veterinary Eye Care Market 2024-2028

  • Report
  • 166 Pages
  • Global
From
Global Veterinary Pain Management Market 2024-2028 - Product Image

Global Veterinary Pain Management Market 2024-2028

  • Report
  • 159 Pages
  • Global
From
Veterinary Rapid Test Kits Market - Global Outlook & Forecast 2023-2028 - Product Image

Veterinary Rapid Test Kits Market - Global Outlook & Forecast 2023-2028

  • Report
  • 274 Pages
  • Global
From
Global Markets for Animal Therapeutics and Diagnostics - Product Image

Global Markets for Animal Therapeutics and Diagnostics

  • Report
  • 303 Pages
  • Global
From
Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 142 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.